BIM
NVCR icon

BlackRock Investment Management’s NovoCure NVCR Stock Holding History

BlackRock Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.45M Sell
184,637
-362
-0.2% -$2.91K ﹤0.01% 2443
2016
Q3 		$1.58M Sell
184,999
-479
-0.3% -$4.37K ﹤0.01% 2349
2016
Q2 		$2.17M Buy
185,478
+157,295
+558% +$1.97M ﹤0.01% 2033
2016
Q1 		$408K Buy
28,183
+582
+2% +$8.35K ﹤0.01% 2969
2015
Q4 		$617K Buy
+27,601
New +$659K ﹤0.01% 2907

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
CCM
Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's NVCR Position: Q4 2016 in Review

BlackRock Investment Management reduced its NovoCure (NVCR) stake by 0.2% in Q4 2016, selling an estimated $2.91K and leaving 184,637 shares worth $1.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2443.

BlackRock Investment Management first reported a position in NVCR in Q4 2015 and has held it in 5 quarters since. The position peaked at $2.17M in Q2 2016. 78 funds tracked by Wall St. Rank hold NVCR as of Q4 2016.

  • BlackRock Investment Management held 184,637 shares of NovoCure worth $1.45M as of Q4 2016.
  • BlackRock Investment Management sold 362 NovoCure shares in Q4 2016, an estimated $2.91K.
  • NovoCure made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2443 holding.
  • BlackRock Investment Management first reported a position in NovoCure in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Investment Management's NovoCure position peaked at $2.17M in Q2 2016.
  • 78 funds tracked by Wall St. Rank held NovoCure as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.